[Prolonged clinical study of the LA, 313-B-xanthinol niacinate pentosan sulfonate ester combination in various forms of hypertension].
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents; D001794:Blood Pressure / Q000187:drug effects; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010426:Pentosan Sulfuric Polyester / Q000627:therapeutic use; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use*; D013806:Theophylline / Q000031:analogs & derivatives*; D014237:Trichlormethiazide / Q000627:therapeutic use; D014665:Vasodilator Agents; D014971:Xanthinol Niacinate / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D004338:Drug Combinations; D046948:Secologanin Tryptamine Alkaloids; D014665:Vasodilator Agents; D006852:Hydrochlorothiazide; D010426:Pentosan Sulfuric Polyester; D014971:Xanthinol Niacinate; D013806:Theophylline; D014237:Trichlormethiazide
Estudio clínico prolongado de la asociación LA. 313-B-xantinol niacinato-éster pentosano sulfónico en hipertensiones diversas